Table 3. Univariate and multivariate Cox regression analyses of COL3A1 mRNA expression and clinical variables for overall and disease-free survival of CRC patientsa.
Survival | Methods | Variables | βb | SE (β)c | Wald χ2 | p | Hazard ratio | 95% CId | |
---|---|---|---|---|---|---|---|---|---|
Low | Upper | ||||||||
Overall-survival | |||||||||
Univariate Cox regression | |||||||||
Age | 0.006 | 0.009 | 0.472 | 0.492 | 1.006 | 0.988 | 1.025 | ||
COL3A1 | 0.720 | 0.247 | 8.517 | 0.004 | 2.055 | 1.267 | 3.333 | ||
Grade | 0.695 | 0.241 | 8.311 | 0.004 | 2.004 | 1.249 | 3.215 | ||
Recurrence | 1.569 | 0.308 | 25.958 | 0.000 | 4.801 | 2.625 | 8.778 | ||
Sex | 0.100 | 0.237 | 0.176 | 0.675 | 1.105 | 0.694 | 1.759 | ||
Stage | 1.049 | 0.154 | 46.482 | 0.000 | 2.854 | 2.111 | 3.859 | ||
Multivariate Cox regression | |||||||||
Recurrence | 1.407 | 0.315 | 20.010 | 0.000 | 4.084 | 2.205 | 7.565 | ||
Stage | 0.441 | 0.207 | 4.531 | 0.033 | 1.554 | 1.036 | 2.333 | ||
Disease-Free survival | |||||||||
Univariate Cox regression | |||||||||
Age | 0.003 | 0.008 | 0.116 | 0.733 | 1.003 | 0.986 | 1.020 | ||
COL3A1 | 0.500 | 0.226 | 4.903 | 0.027 | 1.648 | 1.059 | 2.565 | ||
Grade | 0.692 | 0.230 | 9.062 | 0.003 | 1.997 | 1.273 | 3.133 | ||
Recurrence | 2.272 | 0.293 | 60.110 | 0.000 | 9.703 | 5.463 | 17.235 | ||
Sex | 0.051 | 0.222 | 0.052 | 0.819 | 1.052 | 0.681 | 1.626 | ||
Stage | 0.985 | 0.141 | 48.820 | 0.000 | 2.677 | 2.031 | 3.528 | ||
Multivariate Cox regression | |||||||||
Recurrence | 2.113 | 0.299 | 49.839 | 0.000 | 8.276 | 4.603 | 14.882 | ||
Stage | 0.429 | 0.197 | 4.742 | 0.029 | 1.536 | 1.044 | 2.259 |
The analysis was performed using the Smith Colorectal dataset from the Oncomine cancer gene expression microarray DB (https://www.oncomine.org/resource/login.html).
β, regression coefficient.
SE, standard error.
CI, confidence interval.